Prasanna Vasudevan Iyengar Selected Research

Enzymes

12/2017	The roles of ubiquitin modifying enzymes in neoplastic disease.
4/2017	Regulation of Ubiquitin Enzymes in the TGF-β Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Prasanna Vasudevan Iyengar Research Topics

Disease

8	Neoplasms (Cancer) 01/2023 - 04/2017
3	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2019
3	Carcinogenesis 01/2021 - 04/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Triple Negative Breast Neoplasms 01/2020
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2018

Drug/Important Bio-Agent (IBA)

3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 04/2017
3	UbiquitinIBA 01/2021 - 04/2017
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 10/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2018
2	EnzymesIBA 12/2017 - 04/2017
1	Long Noncoding RNAIBA 01/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2022
1	Proteins (Proteins, Gene)FDA Link 10/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2022
1	TNF Receptor-Associated Factor 4IBA 10/2022
1	CarcinogensIBA 10/2022
1	6-formylindolo(3,2-b)carbazoleIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	CytokinesIBA 01/2022
1	Ligases (Synthetase)IBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Deubiquitinating EnzymesIBA 01/2020
1	Bone Morphogenetic Protein ReceptorsIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	raf KinasesIBA 01/2018
1	ON 01910IBA 01/2018

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2018